Terapia Génica del Cáncer
TGC
![Foto de Terapia Génica del Cáncer](/img/uploaded/2638e8f8b318fa3e2dc194b3248c709e.jpg)
![Foto de Oslo University Hospital](/img/noimage_org.png)
Oslo University Hospital
Oslo, NoruegaPublicaciones en colaboración con investigadores/as de Oslo University Hospital (2)
2021
-
Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
The Lancet Respiratory Medicine, Vol. 9, Núm. 6, pp. 613-621
2018
-
Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO
Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227